Analysis Verbio Vereinigte Bioenergie AG (VBVBF)
6/3/2024
Analysis of Verbio Vereinigte Bioenergie AG (VBVBF)
Verbio Vereinigte Bioenergie AG (VBVBF) is showing a consistent closing price of 22.54 over the past several days. The Relative Strength Index (RSI) indicator is around 67.77, indicating a moderate level of momentum. The Moving Average Convergence Divergence (MACD) indicator is positive, with the MACD line above the signal line, suggesting a bullish trend.The Moving Average (MA) indicator is also around 22.54, aligning with the closing price. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all close to the current price, indicating stability in the stock's performance.
Overall, Verbio Vereinigte Bioenergie AG seems to be trading in a tight range with some bullish momentum based on the MACD indicator. Traders and investors may want to monitor for a potential breakout or reversal in the coming days.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow (TTM) is $110.56 billion, and levered free cash flow (TTM) is $84.73 billion.
- **Balance Sheet**: Total cash (MRQ) is $67.15 billion, total debt (MRQ) is $104.59 billion, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- **Profit Margin**: The profit margin is 26.31%.
- **Income Statement**: EBITDA is $131.39 billion, revenue (TTM) is $381.62 billion, diluted EPS (TTM) is $6.43, gross profit (TTM) is $169.15 billion, revenue per share (TTM) is $24.537, net income to common (TTM) is $100.39 billion, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- **Margins**: Operating margin is 30.74%.
- **Returns**: Return on assets (TTM) is 22.07%, and return on equity (TTM) is 147.25%.
2. **Stock Statistics**:
- **Shares**: Float shares are 15.31 billion, shares short are 99.29 million, shares outstanding are 15.33 billion.
- **Ratios**: Short ratio is 1.53, insider ownership is 5.22%, and institutional ownership is 57.59%.
3. **Valuation Metrics**:
- **Ratios**: PEG ratio is 26.32, forward PE is 26.32, trailing PE is 29.59, price to book (MRQ) is 39.34, price to sales (TTM) is 7.65, enterprise value is $2.95 trillion, enterprise to EBITDA is 22.76, and enterprise to revenue is 7.73.
- **Market Cap**: Market capitalization is $2.92 trillion.
4. **Stock Price Summary**:
- **Performance**: Beta is 1.264, 50-day moving average is $176.26, 200-day moving average is $181.04, 52-week low is $164.08, 52-week high is $199.62, and 52-week change is 6.85%.
5. **Dividends and Splits**:
- **Dividends**: Payout ratio is 14.93%, dividend date is 2024-05-16, ex-dividend date is 2024-05-10, forward annual dividend rate is $1, 5-year average dividend yield is 0.73%, forward annual dividend yield is 0.53%, trailing annual dividend rate is $0.97, and trailing annual dividend yield is 0.51%. Last split date was 2020-08-31 with a 4-for-1 split.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate but steady growth in sales for both the upcoming quarters and the next fiscal year, indicating positive performance and investor confidence in the company's future prospects.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight slowdown compared to the past 5 years but still showing healthy growth prospects in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the market. It's important to consider these different perspectives when making investment decisions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in sales from FY 2020 to FY 2022, followed by a slight decrease in FY 2023.
- Overall, there has been a positive revenue growth trend over the past four years, with fluctuations in between.
These revenue figures provide insights into the company's performance and its ability to generate income from its operations.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $290,437,000,000 in 2023.
5. Shareholders' equity has shown variations but has generally been positive, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth compared to the EPS of $6.10 for the current fiscal year.
Overall, the analysts' estimates point towards a positive outlook with expected growth in both quarterly and annual earnings per share for the company.
MACD of VBVBF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
